1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. News
  7. Summary
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
Real-time Estimate Cboe Europe  -  05/23 07:59:06 am EDT
555.00 CHF   +0.98%
05/18Lonza Opens New Facility for Kodiak Sciences' Retinal Diseases Drug
MT
05/09Lonza, ALSA Ventures Partner To Support Development Of Small Molecule Drug Candidates
MT
05/09LONZA GROUP AG : Ex-dividend day for final dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Lonza JV Bacthera, Seres to Jointly Produce Potential Gut Infection Treatment

11/10/2021 | 03:43am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
CHR. HANSEN HOLDING A/S 0.08% 523.2 Delayed Quote.1.51%
LONZA GROUP AG 0.91% 555.2 Delayed Quote.-27.84%
SERES THERAPEUTICS, INC. 4.69% 3.57 Delayed Quote.-57.14%
All news about LONZA GROUP AG
05/18Lonza Opens New Facility for Kodiak Sciences' Retinal Diseases Drug
MT
05/09Lonza, ALSA Ventures Partner To Support Development Of Small Molecule Drug Candidates
MT
05/09LONZA GROUP AG : Ex-dividend day for final dividend
FA
05/09LONZA GROUP AG : Ex-dividend day for Distribution from share premium account
FA
05/06EuroAPI gains on market debut after spin-off from Sanofi
RE
05/05LONZA GROUP AG : Dividends
CO
05/05LONZA GROUP AG : Proxy Statments
CO
04/29LONZA : to Divest its Quakertown Site Specialized in Particle Size Reduction; Business to ..
PU
04/29Investor group led by Derek Hennecke, TJ Higley, Mark Bamforth, Bill Mitchell and other..
CI
04/26Luzhu Biotech Develops Recombinant Herpes Zoster Vaccine and Bispecific Antibody using ..
AQ
More news
Analyst Recommendations on LONZA GROUP AG
More recommendations
Financials
Sales 2022 6 152 M 6 307 M 6 307 M
Net income 2022 1 064 M 1 091 M 1 091 M
Net cash 2022 423 M 433 M 433 M
P/E ratio 2022 38,3x
Yield 2022 0,60%
Capitalization 40 774 M 41 796 M 41 796 M
EV / Sales 2022 6,56x
EV / Sales 2023 5,84x
Nbr of Employees 16 218
Free-Float 98,6%
Chart LONZA GROUP AG
Duration : Period :
Lonza Group AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 549,60 CHF
Average target price 796,79 CHF
Spread / Average Target 45,0%
EPS Revisions
Managers and Directors
Pierre-Alain Ruffieux Chief Executive Officer
Philippe Deecke Chief Financial Officer
Albert M. Baehny Chairman
Stefan Stoffel Head-Small Molecules Exclusive Synthesis Operation
Werner J. Bauer Independent Director
Sector and Competitors
1st jan.Capi. (M$)
LONZA GROUP AG-27.84%41 796
MODERNA, INC.-46.35%54 195
IQVIA HOLDINGS INC.-28.46%38 202
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567
ALNYLAM PHARMACEUTICALS, INC.-22.00%15 980